Alto Neuroscience Inc. (ANRO)
4.31
-0.13 (-2.93%)
At close: Jan 15, 2025, 3:59 PM
4.30
-0.23%
After-hours Jan 15, 2025, 04:10 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 |
| Revenue | n/a | n/a | 210.00K |
| Cost of Revenue | 373.00K | 342.00K | 145.00K |
| Gross Profit | -373.00K | -342.00K | 65.00K |
| Operating Income | -37.81M | -29.19M | -12.06M |
| Interest Income | 2.35M | 114.00K | 2.00K |
| Pretax Income | -36.30M | -27.71M | -9.19M |
| Net Income | -36.30M | -27.71M | -9.19M |
| Selling & General & Admin | 7.52M | 5.16M | 3.75M |
| Research & Development | 30.29M | 23.69M | 8.37M |
| Other Expenses | n/a | n/a | n/a |
| Operating Expenses | 37.81M | 28.85M | 12.12M |
| Interest Expense | 1.37M | n/a | n/a |
| Selling & Marketing Expenses | n/a | -342.00K | -145.00K |
| Cost & Expenses | 37.81M | 29.19M | 12.27M |
| Income Tax | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 26.88M | 25.57M | 25.57M |
| Shares Outstanding (Diluted) | 26.88M | 25.57M | 25.57M |
| EPS (Basic) | -1.35 | -1.08 | -0.36 |
| EPS (Diluted) | -1.35 | -1.08 | -0.36 |
| EBITDA | -34.56M | -27.37M | -9.04M |
| Depreciation & Amortization | 373.00K | 342.00K | 145.00K |